Catalyst Wire Dossier Catalyst Wire Dossier

EIDD-2801

molnupiravir · Ridgeback Biotherapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EIDD-2801, covering 2021-07-19 to 2021-07-19. Get the full timeline:

Most recent: Clinical Trial Update: COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers [Phase 1]

See pricing